1. Predictors of mortality in COVID-19 patients at Kinshasa Medical Center and a survival analysis: a retrospective cohort study
- Author
-
Yannick Nlandu, Danny Mafuta, Junior Sakaji, Melinda Brecknell, Yannick Engole, Jessy Abatha, Jean-Robert Nkumu, Aliocha Nkodila, Marie-France Mboliassa, Olivier Tuyinama, Dauphin Bena, Yves Mboloko, Patrick Kobo, Patrick Boloko, Joseph Tshangu, Philippe Azika, Jean-Pierre Kanku, Pally Mafuta, Magloire Atantama, Jean-Michel Mavungu, Rosita Kitenge, Asma Sehli, Karel Van Eckout, Cathy Mukuku, Léo Bergeret, David Benchetritt, Golan Kalifa, Ahmed Rodolphe, and Justine Bukabau
- Subjects
COVID-19 ,Mortality ,African people ,Procalcitonin ,Acute kidney injury ,Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background Despite it being a global pandemic, there is little research examining the clinical features of severe COVID-19 in sub-Saharan Africa. This study aims to identify predictors of mortality in COVID-19 patients at Kinshasa Medical Center (KMC). Methods In this retrospective, observational, cohort study carried out at the Kinshasa Medical Center (KMC) between March 10, 2020 and July 10, 2020, we included all adult inpatients (≥ 18 years old) with a positive COVID-19 PCR result. The end point of the study was survival. The study population was dichotomized into survivors and non-survivors group. Kaplan–Meier plot was used for survival analyses. The Log-Rank test was employed to compare the survival curves. Predictors of mortality were identified by Cox regression models. The significance level of p value was set at 0.05. Results 432 patients with confirmed COVID-19 were identified and only 106 (24.5%) patients with moderate, severe or critical illness (mean age 55.6 ± 13.2 years old, 80.2% were male) were included in this study, of whom 34 (32%) died during their hospitalisation. The main complications of the patients included ARDS in 59/66 (89.4%) patients, coagulopathy in 35/93 (37.6%) patients, acute cardiac injury in 24/98 (24.5%) patients, AKI in 15/74 (20.3%) patients and secondary infection in 12/81 (14.8%) patients. The independent predictors of mortality were found to be age [aHR 1.38; 95% CI 1.10–1.82], AKI stage 3 [aHR 2.51; 95% CI 1.33–6.80], proteinuria [aHR 2.60; 95% CI 1.40–6.42], respiratory rate [aHR 1.42; 95% CI 1.09–1.92] and procalcitonin [aHR 1.08; 95% CI 1.03–1.14]. The median survival time of the entire group was 12 days. The cumulative survival rate of COVID-19 patients was 86.9%, 65.0% and 19.9% respectively at 5, 10 and 20 days. Levels of creatinine (p = 0.012), were clearly elevated in non-survivors compared with survivors throughout the clinical course and increased deterioration. Conclusion Mortality rate of COVID-19 patients is high, particularly in intubated patients and is associated with age, respiratory rate, proteinuria, procalcitonin and acute kidney injury.
- Published
- 2021
- Full Text
- View/download PDF